Cancer feature: cnaPANCAN333

ABCD1 ARHGAP4 ATP2B3 ATP6AP1 AVPR2 BCAP31 BGN BRCC3 CETN2 CLIC2 CMC4 CSAG1 CTAG1A CTAG1B CTAG2 DKC1 DNASE1L1 DUSP9 EMD F8 F8A1 F8A2 F8A3 FAM3A FAM50A FAM58A FLNA FUNDC2 G6PD GAB3 GABRA3 GABRE GABRQ GDI1 H2AFB1 H2AFB2 H2AFB3 HAUS7 HCFC1 IDH3G IKBKG IRAK1 L1CAM LAGE3 LCA10 MAGEA1 MAGEA10 MAGEA12 MAGEA2 MAGEA2B MAGEA3 MAGEA4 MAGEA6 MECP2 MPP1 MTCP1 NAA10 NSDHL OPN1LW OPN1MW OPN1MW2 PDZD4 PLXNA3 PLXNB3 PNCK PNMA3 PNMA5 PNMA6A PNMA6B PNMA6C PNMA6D RAB39B RENBP RPL10 SLC10A3 SLC6A8 SMIM9 SRPK3 SSR4 TAZ TEX28 TEX28P1 TEX28P2 TKTL1 TMEM187 TMLHE TREX2 U82695.9 UBL4A VBP1 ZFP92 ZNF185 ZNF275

Known Driver Genes: RPL10

Copy number alternation: gain

GSK2830371A

The Genomics of Drug Sensitivity in Cancer Project is a collaboration between the Cancer Genome Project at the Wellcome Sanger Institute (UK) and the Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center (USA). This work is funded by Wellcome.

Users have a non-exclusive, non-transferable right to use data files for internal proprietary research and educational purposes, including target, biomarker and drug discovery. Excluded from this licence are use of the data (in whole or any significant part) for resale either alone or in combination with additional data/product offerings, or for provision of commercial services.
Please note: The data files are experimental and academic in nature and are not licensed or certified by any regulatory body. Genome Research Limited provides access to data files on an “as is” basis and excludes all warranties of any kind (express or implied).

Genomics of Drug Sensitivity in Cancer